ImmunoBridge Shares Gain 0.8% as Institutions Buy, Retailers Bet on Q2 Upside
IBRX•ImmunoBridge’s shares climbed 0.8% today as institutional investors boosted their positions, signaling renewed confidence. Retail traders ramped up bullish bets ahead of the company’s Q2 earnings release, reflecting expectations of a significant upside surprise.
1. Institutional Investors Increase Stakes
SEC filings reveal that several hedge funds and mutual funds raised their ImmunoBridge positions this quarter, lifting institutional ownership to a multi-quarter high. The shift underscores growing confidence ahead of the company’s Q2 earnings announcement.
2. Retail Traders Position for Q2 Upside
Options markets recorded a pronounced uptick in call open interest as retail investors loaded up on bullish contracts. Traders are betting on a significant upside surprise in quarterly revenue and potential guidance upgrades.
